Risk factors for massive blood transfusion in cytoreductive surgery: A multivariate analysis of 243 procedures

Annals of Surgical Oncology

Volumn 16, Issue 8, 2009, Pages 2195-2203

  Saxena, Akshat ^a   Yan, Tristan D ^a   Chua, Terence C ^a   Fransi, Sal ^a   Almohaimeed, Khaled ^a   Ahmed, Sulman ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; DOXORUBICIN; HEMOGLOBIN; HEPARIN; MITOMYCIN C;

ADULT; ARTICLE; BLEEDING; BLOOD CONSERVATION; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MESOTHELIOMA; MORBIDITY; MULTIVARIATE ANALYSIS; OVARY CANCER; PERITONEUM CANCER; PREOPERATIVE EVALUATION; RISK FACTOR; SURGICAL RISK; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 67650783176     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0484-7     Document Type: Article

References (44)

1. B Sadeghi C Arvieux O Glehen 2000 Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 2 358 363
2. VJ Verwaal S van Ruth E de Bree 2003 Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 20 3737 3743
3. TD Yan D Black R Savady PH Sugarbaker 2006 Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol 24 24 4011 4019
4. TD Yan D Black R Savady PH Sugarbaker 2007 A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 14 2 484 492
5. TD Yan L Welch D Black PH Sugarbaker 2007 A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann Oncol 18 5 827 834
6. TD Yan M Links S Fransi 2007 Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a Nationally Funded Peritonectomy Center Ann Surg Oncol 14 8 2270 2280
7. P Piso M-H Dahlke M Loss H Schlitt 2004 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer World J Surg Oncol 2 1 21
8. P Shen EA Levine J Hall 2003 Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin c after cytoreductive surgery for patients with peritoneal carcinomatosis Arch Surg 138 1 26 33
9. S Kusamura D Baratti R Younan 2007 Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity Ann Surg Oncol 14 9 2550 2558
10. N Gusani S Cho C Colovos 2008 Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 3 754 763
11. S van Ruth RAA Mathot RW Sparidans 2004 Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy Clin Pharmacokin 43 2 131 143
12. R Weber N Jabbour R Martin 2008 Anemia and transfusions in patients undergoing surgery for cancer Ann Surg Oncol 15 1 34 45
13. MP Busch SH Kleinman GJ Nemo 2003 Current and emerging infectious risks of blood transfusions JAMA 289 8 959 962
14. D Stainsby L Williamson H Jones H Cohen 2004 6 Years of SHOT reporting-its influence on UK blood safety Transfus Apher Sci 31 2 123 131
15. WJ Hyung SH Noh DW Shin 2002 Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer Ann Surg Oncol 9 1 5 12
16. Y Makino A Yamanoi T Kimoto 2000 The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma Am J Gastroenterol 95 5 1294 1300
17. M Tachibana H Tabara T Kotoh 1999 Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer Am J Gastroenterol 94 3 757 765
18. ASA. New classification of physical status. Anesthesiology. 1963;24.
19. P Jacquet PH Sugarbaker 1996 Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 359 374
20. PH Sugarbaker 1995 Peritonectomy procedures Ann Surg 221 29 42
21. D Baratti S Kusamura D Nonaka 2008 Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Ann Surg Oncol 15 2 526 534
22. O Glehen E Cotte V Schreiber 2004 Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin Br J Surg 91 6 747 754
23. EA Levine JHt Stewart GB Russell 2007 Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures J Am Coll Surg 204 5 943 953 discussion 953-5
24. TD Yan EA Brun CA Cerruto 2007 Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma Ann Surg Oncol 14 1 41 49
25. PH Sugarbaker 2001 Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome Eur J Surg Oncol 27 3 239 243
26. S Mercadante V Gebbia A Marrazzo S Filosto 2000 Anaemia in cancer: pathophysiology and treatment Cancer Treat Rev 26 4 303 311
27. AA Ayantunde MY Ng S Pal 2008 Analysis of blood transfusion predictors in patients undergoing elective oesophagectomy for cancer BMC Surg 8 3
28. V Verma RE Schwarz 2007 Factors influencing perioperative blood transfusions in patients with gastrointestinal cancer J Surg Res 141 1 97 104
29. S Benoist Y Panis V Pannegeon 2001 Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients Surgery 129 4 433 9
30. C Schmidt M Creutzenberg P Piso 2008 Peri-operative anesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Anaesthesia 63 4 389 395
31. T Shih C Lindley 2006 Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies Clin Ther 28 11 1779 1802
32. VJ Verwaal H van Tinteren SV Ruth FA Zoetmulder 2004 Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol 85 2 61 67
33. D Elias D Goere F Blot 2007 Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43°C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients Ann Surg Oncol 14 6 1818 1824
34. AD Stephens R Alderman D Chang 1999 Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique Ann Surg Oncol 6 8 790 796
35. K Janatpour PV Holland 2002 Noninfectious serious hazards of transfusion Curr Hematol Rep 1 2 149 155
36. EC Vamvakas 2002 Possible mechanisms of allogeneic blood transfusion-associated postoperative infection Transfus Med Rev 16 2 144 160
37. GE Hill WH Frawley KE Griffith 2003 Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis J Trauma 54 5 908 914
38. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006(1):CD005033.
39. N Kosmadakis E Messaris A Maris 2003 Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study Ann Surg 237 3 417 421
40. TG Monk LT Goodnough ME Brecher 1999 A prospective randomized comparison of three blood conservation strategies for radical prostatectomy Anesthesiology 91 1 24 33
41. MM Heiss W Mempel C Delanoff 1994 Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery J Clin Oncol 12 9 1859 1867
42. MM Heiss W Mempel KW Jauch 1993 Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery Lancet 342 8883 1328 1333
43. OR Busch WC Hop MA Hoynck van Papendrecht 1993 Blood transfusions and prognosis in colorectal cancer N Engl J Med 328 19 1372 1376
44. Davies L, Brown TJ, Haynes S, et al. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess. 2006;10(44):iii-iv, ix-x, 1-210.